[BIOD] Biodel Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 0.65 Change: 0 (0%)
Ext. hours: Change: 0 (0%)

chart BIOD

Refresh chart

Description: Biodel Inc., a specialty biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes in the United States. It is involved in developing proprietary insulin formulations for type 1 and type 2 diabetes patients; ultra-rapid-acting insulin analog-based formulations; glucagon formulations and presentations for use as a rescue treatment for diabetes patients experiencing severe hypoglycemia or very low concentrations of blood glucose; and other recombinant human insulin-based formulations. The company was founded in 2003 and is headquartered in Danbury, Connecticut.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS-0.24 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E-2.54
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-77.5% ROE-88.89% ROI
Current Ratio8.74 Quick Ratio Long Term Debt/Equity Debt Ratio0.13
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities2.17 M Cash From Investing Activities-20 K Cash From Operating Activities-8.99 M Gross Profit
Net Profit-4.36 M Operating Profit-4.53 M Total Assets18.75 M Total Current Assets18.38 M
Total Current Liabilities2.1 M Total Debt Total Liabilities2.4 M Total Revenue
Technical Data
High 52 week0.75 Low 52 week0.23 Last close0.65 Last change6.56%
RSI57.63 Average true range0.09 Beta0.77 Volume
Simple moving average 20 days3.26% Simple moving average 50 days26.12% Simple moving average 200 days66.62%
Performance Data
Performance Week12.07% Performance Month12.07% Performance Quart58.54% Performance Half71.05%
Performance Year80.56% Performance Year-to-date91.18% Volatility daily8.13% Volatility weekly18.18%
Volatility monthly37.26% Volatility yearly129.07% Relative Volume0% Average Volume740.2 K
New High New Low

News

2019-05-10 01:50:09 | Edited Transcript of BIOD earnings conference call or presentation 9-May-19 2:00pm GMT

2019-03-07 17:10:11 | Edited Transcript of BIOD earnings conference call or presentation 7-Mar-19 1:30pm GMT

2018-11-13 15:21:22 | Edited Transcript of BIOD earnings conference call or presentation 13-Nov-18 1:30pm GMT

2018-08-20 17:45:22 | Edited Transcript of BIOD earnings conference call or presentation 7-Aug-18 12:30pm GMT

2018-05-17 13:52:49 | Edited Transcript of BIOD earnings conference call or presentation 17-May-18 12:30pm GMT

2018-03-15 21:20:59 | Edited Transcript of BIOD earnings conference call or presentation 15-Mar-18 12:30pm GMT

2017-03-14 07:07:04 | Q4 2016 Albireo Pharma Inc Earnings Release - Before Market Open

2016-11-04 17:09:11 | ALBIREO PHARMA, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Creation of a Direct Fin

2016-11-03 11:30:00 | Albireo Completes Transaction with Biodel to Create Publicly Traded Company Focused on Orphan Pediatric Liver Diseases

2016-11-02 17:00:24 | BIODEL INC Files SEC form 8-K, Termination of a Material Definitive Agreement

2016-11-01 00:13:05 | Proxy Advisory Firms, ISS, Glass Lewis Recommend Biodel Stockholders Vote in Favor of the Proposals Necessary to Complete the Company's Planned Combination with Albireo Limited

2016-11-01 00:13:05 | Biodel Announces Adjournment of Annual Meeting until Thursday, October 27, Urges Stockholders to Vote

2016-10-28 11:20:22 | Here Are Three Big Biotech Movers And Our Take On What’s Next

2016-10-26 19:18:00 | Biodel Announces Intent to Further Adjourn Annual Meeting until Thursday, November 3

2016-10-24 16:38:05 | BIODEL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits

2016-10-24 16:01:00 | Biodel Announces Adjournment of Annual Meeting until Thursday, October 27, Urges Stockholders to Vote

2016-10-19 06:05:35 | BIODEL INC Files SEC form 8-K, Other Events

2016-10-17 08:36:40 | BIODEL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits

2016-10-17 08:30:00 | Proxy Advisory Firms, ISS, Glass Lewis Recommend Biodel Stockholders Vote in Favor of the Proposals Necessary to Complete the Company's Planned Combination with Albireo Limited

2016-10-11 17:24:29 | BIODEL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits

2016-10-05 13:55:28 | Here’s Why Biodel Inc BIOD Just Gained, And What It Means

2016-10-03 16:32:37 | BIODEL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits

2016-10-01 00:11:06 | Biodel Announces 2016 Annual Meeting of Stockholders Set for October 24, 2016; Outlines Plan to Regain Compliance With Nasdaq Listing Requirements

2016-09-26 16:30:00 | Biodel Announces 2016 Annual Meeting of Stockholders Set for October 24, 2016; Outlines Plan to Regain Compliance With Nasdaq Listing Requirements

2016-09-22 06:03:39 | BIODEL INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf

2016-09-09 16:09:20 | BIODEL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agree

2016-09-01 00:03:05 | Biodel Reports Third Quarter Fiscal Year 2016 Financial Results

2016-08-19 13:04:29 | BIODEL INC Financials

2016-08-11 16:34:53 | Biodel Reports Third Quarter Fiscal Year 2016 Financial Results

2016-06-01 00:23:02 | Biodel Reports Second Quarter Fiscal Year 2016 Financial Results

2016-05-26 09:30:01 | The Zacks Analyst Blog Highlights: XenoPort, Biodel and AbbVie

2016-05-25 15:02:07 | Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Drug Fares Well

2016-05-25 09:38:01 | Biodel/Albireo Limited to Combine; Focus on Liver Diseases

2016-05-24 20:04:23 | Biodel Inc. and Albireo Limited Agree to Combine

2016-05-09 17:00:00 | Biodel Reports Second Quarter Fiscal Year 2016 Financial Results

2016-05-06 15:54:07 | Radius Health RDUS Reports Wider-than-Expected Q1 Loss

2016-02-16 07:05:00 | Biodel Reports First Quarter Fiscal Year 2016 Financial Results

2016-01-29 08:00:00 | Biodel Announces Restructuring Update

2016-01-15 06:37:00 | 3 Biotech Stocks Under $10 to Trade for Big Gains

2015-12-28 08:25:01 | Auris Medical Holding EARS Looks Good: Stock Up 23.8%

2015-12-17 16:14:36 | Biodel Reports Fourth Quarter and Fiscal Year 2015 Financial Results

2015-12-14 07:00:00 | Biodel to Report Fourth Quarter and Fiscal Year 2015 Financial Results on December 17, 2015

2015-11-27 09:57:14 | What Do Hedge Funds Think of EnteroMedics Inc ETRM?

2015-11-24 17:11:24 | Do Hedge Funds Love AEterna Zentaris Inc. USA AEZS?

2015-11-24 10:36:45 | AEterna Zentaris Inc. USA AEZS Making Another Monster Move Today

2015-11-03 16:30:00 | Biodel Announces Clinical and Corporate Updates

2015-10-19 16:30:00 | Biodel Announces Data Presentations at the Diabetes Technology Society Conference

2015-09-24 14:45:02 | These 5 Healthcare Penny Stocks Are Poised To Jump

2014-08-11 07:30:02 | Biodel's insulin drug found effective in trial